RecruitingNCT06378229
Psilocybin-assisted therapy for hospitalized people with treatment-resistant depression
About this title
Read the official source — NCT06378229Medication studyAges 18+Belgium
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- GhentSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 21, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 100
- Sponsor
- University Hospital, Ghent
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Belgium
- Age range
- Over 18 Years
- Official registry ID
- NCT06378229
- Official title
Show the full official title
Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Ghent
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Ghent, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
